drugset / Trial / NCT03055936

Dose-finding Pharmacokinetic Study in Healthy Males

NCT03055936 ↗

Phase 1 Completed 56 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

This is a phase I PK study in healthy males.

Timeline

Start
2017-02-21
Primary completion
2017-06-09
Completion
2017-06-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbidopa Unknown 12.5 mg —
Subject Carbidopa Unknown 25 mg —
Subject Carbidopa Unknown 65 mg —
Subject Levodopa Unknown 50 mg —
Subject Levodopa Unknown 100 mg —
Subject Levodopa Unknown 150 mg —
Subject ODM-104 Unknown 50 mg —
Subject ODM-104 Unknown 100 mg —

Indications

No indication recorded.